Listed

Volitionrx Ltd

VNRXNYSECIK 93314HealthcareFiscal year ends Dec 31

Reports and events: 265 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Volitionrx Ltd, Reports and events
FiledFormWhat it isAccession number
2026-09-2517:00 ET8-K3.02 Unregistered sale of equity0001477932-26-005804
2026-09-1617:30 ETSCHEDULE 13D/AOwnership report, active investor, amended0001493152-26-042962
2026-09-1517:00 ET8-K3.02 Unregistered sale of equity0001477932-26-005620
2026-09-1416:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001477932-26-005578
2026-09-0417:29 ETSCHEDULE 13DOwnership report, active investor0001493152-26-041611
2026-09-0216:45 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001477932-26-005359
2026-09-0221:54 ET8-K3.02 Unregistered sale of equity0001477932-26-005351
2026-08-2417:00 ET8-K3.02 Unregistered sale of equity0001477932-26-005251
2026-08-1316:40 ET10-QQuarterly reportPeriod 2026-06-300001477932-26-004995
2026-08-1316:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001477932-26-004991
2026-08-0717:00 ET8-K3.02 Unregistered sale of equity0001477932-26-004778
2026-07-2116:15 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001477932-26-004421
2026-06-1817:00 ET8-K3.02 Unregistered sale of equity0001477932-26-003932
2026-06-1019:04 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001477932-26-003740
2026-06-0216:21 ETDEF 14AProxy statementPeriod 2026-07-170001477932-26-003587
2026-05-2217:00 ET8-K1.01 Entry into a material agreement0001477932-26-003416
2026-05-1516:45 ET8-K5.02 Departure or appointment of officers or directors0001477932-26-003241
2026-05-1416:21 ET10-QQuarterly reportPeriod 2026-03-310001477932-26-003128
2026-05-1416:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001477932-26-003126
2026-04-3016:45 ET10-K/AAnnual report, amendedPeriod 2025-12-310001477932-26-002685
2026-04-2817:00 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001477932-26-002619
2026-04-2308:45 ET8-K3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits0001477932-26-002472
2026-04-1717:00 ET8-K8.01 Other events0001477932-26-002373
2026-04-0116:30 ET8-K5.07 Shareholder vote results0001477932-26-001940
2026-03-3116:13 ET10-KAnnual reportPeriod 2025-12-310001477932-26-001832
2026-03-3116:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001477932-26-001830
2026-02-2017:15 ET8-K3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001477932-26-000955
2026-02-1117:05 ETDEF 14AProxy statementPeriod 2026-02-100001477932-26-000757
2026-02-0917:26 ET8-K3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits0001477932-26-000714
2026-01-0817:28 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001477932-26-000107
2025-12-1117:00 ET8-K5.02 Departure or appointment of officers or directors0001477932-25-008932
2025-11-1316:18 ET10-QQuarterly reportPeriod 2025-09-300001477932-25-008186
2025-11-1316:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001477932-25-008182
2025-11-1316:06 ET8-K/A1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001477932-25-008179
2025-11-1017:05 ET8-K/A1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001477932-25-008019
2025-11-0717:30 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001477932-25-007984
2025-10-1417:12 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001477932-25-007544
2025-08-1517:16 ET10-Q/AQuarterly report, amendedPeriod 2025-06-300001477932-25-005992
2025-08-1416:54 ET10-QQuarterly reportPeriod 2025-06-300001477932-25-005923
2025-08-1416:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001477932-25-005919
2025-08-0416:21 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001477932-25-005422
2025-06-2016:06 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001477932-25-004721
2025-05-1517:27 ET10-QQuarterly reportPeriod 2025-03-310001477932-25-003853
2025-05-1517:26 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001477932-25-003852
2025-04-2916:18 ETDEF 14AProxy statementPeriod 2025-04-240001477932-25-003069
2025-04-2217:16 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001477932-25-002897
2025-04-0417:22 ET8-K7.01 Regulation FD disclosure0001477932-25-002475
2025-04-0417:20 ETS-1Registration statement0001477932-25-002474
2025-03-3116:18 ET10-KAnnual reportPeriod 2024-12-310001477932-25-002231
2025-03-3116:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001477932-25-002227

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.